CompanyPrivateRockville, MD

Immunomic Therapeutics, Inc

SEC EDGAR ClinicalTrials.gov

10-QAug 6Latest SEC filing, period to Jun 30

Form DJun 2$6.5M sold

July 2026

Immunomic Therapeutics opens Phase 1 trial of ITI-9001 for Japanese Red Cedar pollinosis

Jul 24Trial updateImmunomic Therapeutics, Inc